Sanofi’s Andre Turenne Is Slated to Become Voyager Therapeutics CEO

Voyager Therapeutics (NASDAQ: VYGR) has appointed Andre Turenne to serve as president and CEO of the Cambridge, MA-based gene therapy developer. Turenne will succeed Steven Paul, who is retiring but will remain on Voyager’s board of directors.